Healthtech Startups

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing small molecule therapeutics designed to address nonsense mutation genetic disorders. The company is advancing exaluren for rare kidney diseases including Alport syndrome and ADPKD through clinical trials.

1 investor

Elpida provides automated regulatory compliance monitoring for healthcare brands' digital communications. The platform continuously tracks marketing claims across digital channels to ensure compliance with FDA regulations while accelerating time-to-market for healthcare companies.

1 investor

Mello builds AI agents that automate back-office healthcare operations, working across EMRs, payer portals, labs, and faxes to read, decide, and complete tasks like insurance authorizations and documentation. It targets high-volume medical practices and healthcare groups, delivering reviewed results that staff can approve while reducing manual processing time.

1 investor

Elsee is a wellness benefits platform that reimburses individuals for access to wellness practices including meditation, soft physical activities, natural supplements, and therapeutic services. The company connects users with a network of wellness practitioners and brands to make wellbeing more accessible and affordable.

1 investor

eLuma provides school-based teletherapy services delivering speech-language pathology, occupational therapy, school psychology, and mental health support to K-12 students through a secure digital platform. The company helps districts address staffing shortages and rising caseloads by connecting students with licensed therapists via virtual sessions.

1 investor

Elut is a clinical-stage medical device company developing patented drug-eluting devices that provide controlled, sustained therapeutic release, with a current focus on treating orthopedic and periprosthetic joint infections. Its technology is applied to bone void fillers that deliver local antibiotics over an eight-week period.

1 investor

Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction. Its allograft products serve surgeons performing reconstructive and cardiovascular repair procedures in the medical device and regenerative medicine field.

1 investor

Eluve builds medical AI tools for clinicians, including an ambient scribe that drafts clinical notes, orders, and billing codes from patient conversations, plus clinical decision support and operational analytics. It serves healthcare practices and providers across specialties such as primary care, physical therapy, chiropractic, and counseling.

1 investor

Eluvo is a femtech startup providing integrated women's healthcare through a three-step process combining telehealth access, clinical testing, and treatment services. The company operates both a digital platform and strategically located physical clinics across metro Manila to serve women across all life stages.

1 investor

Emano Flow is a mobile app that uses acoustic technology to objectively measure urinary health symptoms and track patient outcomes before and after medical interventions. It serves urology clinics and healthcare providers seeking objective measurement tools for patient symptom monitoring.

1 investor

Ironleap builds AI products for healthcare businesses, mapping clinical and operational workflows to identify automation opportunities, assess compliance and data risks, and deliver tailored AI solutions. It serves healthcare operations teams aiming to improve efficiency, reduce costs, and enhance patient outcomes.

1 investor

Emblation manufactures compact, portable microwave generator systems for medical and industrial applications. The company serves healthcare providers for oncology, cardiology, and other clinical procedures, as well as industrial, scientific, and academic research institutions.

1 investor

Embleema builds a patient-centric data platform for clinical research and real-world evidence collection, serving pharmaceutical sponsors and research organizations. The platform enables patients to control and share their health data securely while streamlining research operations across sites and investigators.

1 investor

EmblemHealth's Neighborhood Care is a health and wellness program offering free fitness classes, health education workshops, and community events to the public, while providing personalized insurance support and local resource connections to EmblemHealth members. The initiative serves entire communities with emphasis on preventive health and social determinants of well-being.

1 investor

Emblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris. It aims to reduce the risk of procedure-related strokes and damage to the heart, kidneys, and intestines for physicians and patients.

1 investor

Zimmer Biomet develops medical devices and orthopedic solutions for patients and healthcare providers globally. The company operates across more than 100 countries with a focus on advancing patient safety, quality, and diversity in healthcare innovation.

1 investor

Embold Health provides AI-driven care navigation tools and provider-performance analytics built on aggregated claims data covering 230+ million individuals, used to guide members to higher-quality doctors and lower healthcare costs. It serves employers, health plans, healthcare providers, and health tech companies.

1 investor

Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures used to treat conditions such as cancerous tumors, benign prostatic hyperplasia, and uterine fibroids. Its Sniper balloon occlusion microcatheter controls blood flow pressure to direct embolic delivery to target tissue while protecting surrounding tissue.

1 investor

EMC Healthcare develops and sells digital transformation services for elderly care and childcare facilities, including the "OwlCare" monitoring system for care homes and the "Babymoni" nap-check system for nurseries. The company also builds medical/care data analytics platforms, sensor devices, and AI systems, and provides consulting, serving healthcare and care providers in Japan.

1 investor

EMED makes infusion pump systems and subcutaneous delivery devices for patients requiring immunoglobulin therapy and other biologics. The company's portfolio includes mechanical and electronic infusion pumps, needle sets, and accessories designed for both home and clinical use.

1 investor

Emerald Inno develops a contactless health monitoring device that uses radio wave analysis and machine learning to detect human movement and extract clinical health data without wearables or manual data synchronization. The platform serves clinical research and health studies with proprietary algorithms that process behavioral and movement data.

1 investor

Emerald BioAgriculture develops biology-based products and solutions using advanced biomanufacturing processes for plant, animal, and human health across various markets. The company specializes in biochemistry, microbials, enzymes, amino acids, peptides, and nutrients with integrated capabilities from discovery through manufacturing.

1 investor

Emerging Therapy Solutions provides comprehensive management solutions for cell and gene therapies and transplants to payers, self-insured employers, and secondary payers. The company offers patient identification, care navigation, outcomes monitoring, and risk pooling services to help organizations anticipate and manage the costs and complexities of these therapies.

1 investor

Emet Surgical develops ESP (Enhanced Surgical Precision), a software-only AI system that provides real-time anomaly detection with visual overlay guidance during minimally invasive laparoscopic and robotic surgery, helping surgeons identify pathology such as cancerous tissue and endometrial lesions. Built on licensed computer vision and AI IP from the University of Minnesota, it integrates with existing surgical equipment without new hardware or contrast agents and is pursuing FDA 510(k) clearance as a Class II Software as a Medical Device.

1 investor